Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OmniAb (OABI) Research & Development (2022 - 2025)

OmniAb (OABI) has disclosed Research & Development for 4 consecutive years, with $13.9 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 4.53% to $13.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.8 million through Dec 2025, down 13.35% year-over-year, with the annual reading at $47.8 million for FY2025, 13.35% down from the prior year.
  • Research & Development for Q4 2025 was $13.9 million at OmniAb, up from $10.4 million in the prior quarter.
  • The five-year high for Research & Development was $14.8 million in Q4 2023, with the low at $10.4 million in Q3 2025.
  • Average Research & Development over 4 years is $13.0 million, with a median of $13.3 million recorded in 2024.
  • The sharpest move saw Research & Development rose 27.73% in 2023, then decreased 22.07% in 2025.
  • Over 4 years, Research & Development stood at $12.9 million in 2022, then increased by 14.3% to $14.8 million in 2023, then dropped by 9.89% to $13.3 million in 2024, then grew by 4.53% to $13.9 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $13.9 million, $10.4 million, and $10.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.